Cambridge · Seed–Series A · 1 people tracked
Also known as QIMING U.S. VENTURES MANAGEMENT, LLC
Find your way into Qiming Venture Partners USA
88 people in our graph share verified history with the Qiming Venture Partners USA team — schools, employers, funds. One of them is your warm intro.
Investment thesis
The firm positions itself as a hands-on partner to healthcare companies, bringing deep technical expertise, operational experience, an expansive network, and a global mindset. Having built and shaped companies from both the founder and investor sides, the team supports portfolio companies throughout their lifecycle — from early concept through regulatory approval and commercialization — with the aim of making a lasting impact in healthcare.
Source: firm website, verified Sep 1, 2026.
Team · 1 people
from curated
What they invest in
from 4 of 5 portfolio companiesBiotech ×4Healthtech ×2Deep Tech ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro pathBy year:2025 · 22021 · 12017 · 14 dated
Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.
BiotechHealthtechSeattle, US
Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)
BoardIrena Melnikova(Executive Officer)Anna French(Director)Robert Glassman(Director)John Hamer(Director)in
Co-investorsMPM BioImpactDCVC BioSoftBank GroupK2 HealthVenturesSoftBank Vision FundDCVC (Data Collective)
BiotechSan Francisco, US
Jeanmarie Guenot(Executive Officer, Director)Florian Fischer(Director)
BoardLuke Evnin(Director)in
Co-investors+ND CapitalMPM BioImpactQiming Healthcare
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)in
BoardAlicia Levey(Director)Michael Ross(Director)
Co-investorsQiming Venture PartnersSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming Healthcare
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).
BiotechHealthtechBerkeley, US
Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)Thomas Gustafson(Executive Officer)inEmily Conley(Executive Officer, Director)in
BoardEvan Caplan(Director)inCharlotte McKee(Director)
Co-investors5AM VenturesOrbiMedAtlas Venture
Cambridge, US
John Moore(Executive Officer, Director)Franklin Moss(Director)
BoardMark Lester(Director)Andrew Palmer(Director)Scott Gilroy(Director)
Co-investorsKhosla Ventures
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does Qiming Venture Partners USA invest at?
- Qiming Venture Partners USA invests at the Seed, Series A stages.
- What sectors does Qiming Venture Partners USA focus on?
- Qiming Venture Partners USA focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Qiming Venture Partners USA located?
- Qiming Venture Partners USA is headquartered in Cambridge, US.
- Does Qiming Venture Partners USA lead rounds?
- Qiming Venture Partners USA typically participates in rounds rather than leading them.
Co-investors · 7
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Techstars is a startup accelerator and early-stage investor that funds ambitious founders and provides capital, mentorship, and access to a global network of investors, operators, and corporate partners.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
1955 Capital is an early-stage, thesis-driven venture firm founded in 2016 that invests in companies commercializing foundational science across biology, materials, energy, and computation.
Firms observed investing alongside Qiming Venture Partners USA, from public investor directories. Shared companies are the overlap with Qiming Venture Partners USA's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Third Rock Ventures is a venture capital firm that discovers, launches, and builds life sciences and biotechnology companies developing novel medicines and therapies.